As of 2026-03-11, the EV/EBITDA ratio of Gritstone Oncology Inc (GRTS) is 0.07. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GRTS's latest enterprise value is -8.76 mil USD. GRTS's TTM EBITDA according to its financial statements is -124.44 mil USD. Dividing these 2 quantities gives us the above GRTS EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.3x - 14.9x | 14.7x |
| Forward P/E multiples | 18.7x - 23.3x | 20.9x |
| Fair Price | (45.86) - (36.52) | (43.55) |
| Upside | -142532.5% - -113521.5% | -135356.1% |
| Date | EV/EBITDA |